By Dr. John Harrison, PhD, MSc, BSc Senior Government Relations Advisor So you want to import a consumer health product from the U.S.A. to Canada. Good luck! There are many […] Read More >>
By: Rupika Malhotra, MSc – Food, Scientific and Regulatory Affairs Associate February 13, 2012 With the introduction of any new set of guidelines, regulations or changes impacting any sector of […] Read More >>
By Arwen Brooks Quality Assurance and Regulatory Affairs Assistant, dicentra Dec. 15, 2010 — The FDA today announced new steps to target harmful products marketed as dietary supplements, including the […] Read More >>
By: Ashleigh Hampton, MSc December 5, 2011 Previous reports of resveratrol have suggested that resveratrol undergoes extensive metabolism, thus resulting in a low bioavailability of the parent compound (As reviewed […] Read More >>
Manushvi Chadha, BPharm, RA Cert Regulatory Affairs Associate, dicentra Inc. Nanomaterials are engineered molecules whose defining characteristic is their size – they range from 1-100 nanometers where each nano is […] Read More >>
Rupika Malhotra, MSc Scientific and Regulatory Affairs Associate, Dicentra With recent developments and proposed changes to energy drink regulations in Canada, questions on taxation of health harming foods have come […] Read More >>
Clara di Tella, BSc, Pharm QA Regulatory Affairs Specialist, Dicentra The United States Food and Drug Administration along with regulatory agencies from 80 other countries have completed the International Internet […] Read More >>
Ashleigh Hampton, MSc Scientific and Regulatory Affairs Associate, Dicentra There have been some challenges faced while assessing the therapeutic effects of resveratrol in humans. Phase 1 clinical trials have reported […] Read More >>
William Morkel, BSc Senior Quality Assurance and Regulatory Affairs Specialist, Dicentra From late September to mid October the NHPD will be holding information sessions in Montreal, Toronto, Vancouver, and Halifax […] Read More >>
Manushvi Chadha, BPharm, RA Cert Regulatory Associate, Dicentra The FDA recognizes that the production of FDA-regulated products has gone international, with more globalization on the way. Not only wholly manufactured […] Read More >>
Health Canada Update: Non-Medicinal Ingredient Labeling for Nonprescription Drug Products Clara di Tella, BSc, Pharm QA Regulatory Affairs Specialist Health Canada has released a notice to inform drug manufacturers/sponsors of […] Read More >>